MEOH vs SSRM

MEOH exhibits a severe disconnect between its current market price ($59.75) and its fundamental value, with a Piotroski F-Score of 4/9 indicating only stable health and a Graham Number of $25.71 suggesting significant overvaluation. While the stock has seen a massive 123% 1-year price surge, this is not supported by fundamentals, as YoY EPS growth has plummeted by 111.3% and profit margins have shrunk to a razor-thin 2.22%. The high payout ratio (79.57%) combined with declining earnings creates a risk to dividend sustainability. Despite analyst 'buy' ratings, the deterministic metrics signal a speculative bubble or an over-optimistic anticipation of a cyclical recovery.

With a Piotroski F-Score of 4/9, SSRM exhibits stable financial health, though the absence of an Altman Z-Score leaves a gap in bankruptcy risk quantification. The stock is currently priced at $31.75, trading at a premium to its Graham Number ($26.82) but significantly below its growth-based Intrinsic Value ($54.58). While the company shows explosive YoY earnings growth and a very low forward P/E of 6.13, the 'Çöpler Incident' noted in the 10-K represents a critical qualitative risk. Despite a bearish technical trend score, the fundamental valuation and analyst consensus suggest strong upside potential.